Imatinib mesylate (STI-571 Glivec, Gleevec) is an active agent for gastrointestinal stromal tumours, but does not yield responses in other soft-tissue sarcomas that are unselected for a molecular target: Results from an EORTC Soft Tissue and Bone Sarcoma Group phase II study

Verweij J.;Van oosterom A.;Blay J. Y.;Judson I.;Rodenhuis S.;Van der graaf W.;Radford J;Le cesne A.;Hogendoorn P. C. W;Donato Di Paola E;Brown M.;Nielsen O. S

2003-01-01